查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1993872

下一代生物製造市场：依工作流程、应用、产品类型、最终用途、国家及地区划分－全球产业分析、市场规模、市场占有率及2026年至2033年预测

Next-Generation Biomanufacturing Market, By Workflow Type, By Application, By Product, By End Use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
出版日期: | 出版商: AnalystView Market Insights | 英文 387 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年，下一代生物製造市场价值为 443.8039 亿美元，预计从 2026 年到 2033 年将以 6.81% 的复合年增长率成长。

下一代生物製造是指利用先进技术和尖端生产方法生产疫苗、单株抗体、基因疗法和其他生物製药等生物製药製品。与通常依赖大规模、耗时批次製程的传统生物製造不同，这些方法强调更灵活、高效和扩充性的生产系统。连续生物製程、一次性生物反应器、自动化、数位化监控和先进的细胞培养技术等，有助于提高生产效率和产品品质的稳定性，同时满足肿瘤学、罕见疾病和个人化医疗等领域对复杂生物製药日益增长的需求。随着生物製药需求的持续成长，以及製药公司采用先进製造技术来支援专业化生产工艺，下一代生物製造市场正在稳步发展。此外，生物技术研发投入的增加、生物製药生产设施的扩建以及生物技术公司与契约製造组织（CMO）之间的合作，都促进了这些技术在现代生物製药製造中的更广泛应用。

下一代生物製造市场—市场动态

全球对生物製药和先进治疗方法的需求日益增长

下一代生物製造市场的主要驱动力是全球对生物製药（包括单株抗体、疫苗以及基因和细胞疗法）需求的快速成长。随着医疗保健系统越来越依赖先进的生物疗法来治疗癌症、自体免疫感染疾病等疾病，製药公司需要更有效率、扩充性生产能力的生产技术。与传统的间歇式生产相比，下一代生物製造方法，例如连续製程、自动化和模组化製造系统，能够缩短生产週期、提高产品品质并增强营运灵活性。这种不断增长的需求正在推动上游连续生物製造领域的发展，该领域透过提高营运效率和减少设施面积来支持大规模生物製药生产，从而推动市场成长。该领域约占整个市场的45.3%。政府和全球卫生数据也凸显了生物製药生产日益增长的重要性。据世界卫生组织（WHO）称，对灵活和模组化生产技术的投资已使全球生物製药产能增加了30%以上。同时，美国国立卫生研究院 (NIH) 的报告显示，连续生物製程可将生产週期缩短高达 50%，从而显着提高生物製药的生产效率。这些趋势表明，对生物製药日益增长的需求以及政府对先进製造基础设施投资的不断增加，正在加速全球对下一代生物製造技术的应用。

下一代生物製造市场—市场区隔分析：

全球下一代生物製造市场按产品、应用、工作流程类型、最终用途和地区进行细分。

根据产品类型，生物製药市场可分为三大类：连续上游生物製造产品、一次性上游生物製造产品和下游生物製造产品。其中，一次性上游生物製造产品是推动全球下一代生物製造市场发展的主要力量。一次性上游生物製造产品的主要优势在于降低污染风险、降低营运成本、提高生产柔软性。这些产品，包括一次性生物反应器、一次性袋装物料和管路系统，省去了传统不銹钢系统所需的复杂清洗和灭菌流程。这项优势显着缩短了生产週期，并提高了生产效率。这对于生产单株抗体、疫苗、细胞疗法和基因疗法的生物製药公司至关重要。根据美国食品药物管理局(FDA) 统计，近年来核准的生物製药和生物相似药数量稳定成长，推动了对速度更快、适应性更强的生产平台的需求。此外，根据国际药品製造商协会联合会（IFPMA）的报告，生技药品在全球药物研发管线中正迅速占据市场份额，这促使製造商采用一次性技术来加速生产并快速扩大规模。这些优势使得一次性上游工程系统成为全球新一代生物製药设施中最广泛采用的产品类型。

根据应用领域，市场可分为两大类：单株抗体、疫苗、重组蛋白和荷尔蒙。单株抗体（mAb）主导地位的主要原因是其在癌症、自体免疫疾病和感染疾病的治疗中广泛应用。生物製药公司正日益重视单株抗体的研发，这主要得益于其高特异性、强大的治疗效果以及不断增长的全球核准数量。根据美国食品药物管理局（FDA）统计，近年来核准的生物製剂中，单株抗体占相当大的比例，反映了全球对抗体疗法的需求不断增长。此外，世界卫生组织（WHO）也强调了单株抗体疗法在肿瘤和免疫疾病领域应用的不断扩大，这增加了对大规模、高效生物製药製造平台的需求。由于这些治疗方法需要高度可控且可扩展的生产工艺，製造商正越来越多地在上游和下游工艺中采用先进的生物製造技术，这进一步巩固了单株抗体在全球市场的主导地位。

下一代生物製造市场—区域洞察

新一代生物製造市场正经历着显着的地理扩张，北美凭藉其成熟的生物技术和製药公司、先进的研究基础设施以及完善的管理体制，占据了重要的市场份额。美国透过对生物製药、细胞和基因疗法开发以及尖端製造技术（例如连续生物製程和一次性系统）的投资，为该地区做出了重大贡献。美国卫生与公众服务部和国立卫生研究院 (NIH) 等机构的政府计画和资金也支持先进生物製造能力的发展。同时，欧洲也是该市场的重要区域，这得益于其高度发展的製药产业和合作研究倡议。德国、英国、瑞士和法国等国积极参与生物製药的生产和研究，政府计画、学术机构和合约开发与生产组织 (CDMO) 共同推动了新一代生物製造技术在全部区域稳步应用，提升了其在新一代生物製造领域的重要性。

下一代生物製造市场—国家洞察

在全球下一代生物製造市场中，美国凭藉其成熟的生物技术产业、先进的研究基础设施以及对生物製药製造技术的持续投入，处于领先地位。美国拥有众多生物製药公司、研究机构和合约研发生产机构（CDMO），这些机构支持生物製药、疫苗以及细胞和基因疗法的研发和生产。政府措施也促进了市场发展。例如，美国卫生与公众服务部支持了旨在加强国内生物製造能力和促进先进製造技术创新的计画。此外，学术机构、生物技术公司和研究机构之间的合作正在推动下一代生物製造方法的逐步应用，例如连续生产、自动化和一次性生物製程系统。

目录

第一章：下一代生物製造市场概述

  • 分析范围
  • 市场估算期

第二章执行摘要

  • 市场区隔
  • 竞争考察

第三章：下一代生物製造的关键市场趋势

  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 未来市场趋势

第四章：下一代生物製造产业分析

  • PEST分析
  • 波特五力分析
  • 市场成长前景展望图
  • 管理体制分析

第五章：下一代生物製造市场：地缘政治紧张局势加剧的影响

  • 新冠疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：下一代生物製造市场趋势

  • 下一代生物製造市场份额分析（2025 年）
  • 主要製造商的细分数据
    • 对现有公司的分析
    • 新兴企业分析

第七章 下一代生物製造市场：依工作流程类型划分

  • 概述
    • 细分市场占有率分析：依工作流程类型
    • 上游生物製造工作流程
    • 下游生物製造工作流程

第八章：下一代生物製造市场：依应用领域划分

  • 概述
    • 基于细分市场的市场份额分析：按应用领域
    • 单株抗体
    • 疫苗
    • 重组蛋白
    • 荷尔蒙
    • 其他的

第九章 下一代生物製造市场：依产品分类

  • 概述
    • 基于细分市场的市占率分析：按产品
    • 连续上游生物製造产品
    • 一次性上游生物製造产品
    • 下游生物製造产品

第十章 下一代生物製造市场：依最终用途划分

  • 概述
    • 基于细分市场的市场份额分析：按应用领域
    • 生物製药公司
    • 研究机构
    • 受託研究机构

第十一章 下一代生物製造市场：按地区划分

  • 介绍
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 主要製造商：欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 其他欧洲国家
  • 亚太地区
    • 概述
    • 主要製造商：亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 其他亚太国家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 其他拉丁美洲国家
  • 中东和非洲
    • 概述
    • 主要生产商：中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • 其他中东和非洲国家

第十一章：主要供应商分析：下一代生物製造产业

  • 竞争基准
    • 竞争对手仪錶板
    • 竞争定位
  • 公司简介
  • Applikon Biotechnology BV (Netherlands),
  • bbi-biotech GmbH (Germany),
  • Danaher Corporation (US),
  • Eppendorf AG (Germany), Esco Group of Companies (US),
  • GEA Group Aktiengesellschaft (Germany),
  • Meissner Filtration Products, Inc. (US),
  • Merck KGaA (Germany),
  • PBS Biotech, Inc. (US),
  • Pierre Guerin (France),
  • Sartorius AG (Germany),
  • Shanghai Bailun Biotechnology Co. Ltd. (China),
  • Solaris Biotechnology Srl. (Italy),
  • Thermo Fisher Scientific Inc. (US),
  • ZETA GmbH (Austria),
  • Other

第十二章：AnalystView 的全景视图

简介目录
Product Code: ANV6205

Next-Generation Biomanufacturing Market size was valued at US$ 44,380.39 Million in 2025, expanding at a CAGR of 6.81% from 2026 to 2033.

Next-generation biomanufacturing refers to the use of advanced technologies and modern production methods to produce biological products such as vaccines, monoclonal antibodies, gene therapies, and other biopharmaceuticals. Unlike traditional biomanufacturing, which typically relies on large and time-intensive batch processes, these approaches emphasize more flexible, efficient, and scalable production systems. Technologies such as continuous bioprocessing, single-use bioreactors, automation, digital monitoring, and advanced cell-culture techniques help improve manufacturing efficiency and maintain consistent product quality while supporting the increasing demand for complex biologic medicines used in areas such as oncology, rare diseases, and personalized medicine. The Next-Generation Biomanufacturing market is developing steadily as demand for biologic drugs continues to increase and pharmaceutical companies adopt advanced manufacturing technologies to support specialized production processes. In addition, growing investments in biotechnology research, expansion of biopharmaceutical manufacturing facilities, and collaborations between biotechnology firms and contract manufacturing organizations are supporting the wider adoption of these technologies in modern biopharmaceutical production.

Next-Generation Biomanufacturing Market- Market Dynamics

Rising Global Demand for Biologics and Advanced Therapies

A major factor driving the Next-Generation Biomanufacturing Market is the rapidly growing global demand for biologic medicines, including monoclonal antibodies, vaccines, and gene and cell therapies. As healthcare systems increasingly rely on advanced biologic treatments for diseases such as cancer, autoimmune disorders, and infectious conditions, pharmaceutical manufacturers require more efficient and scalable production technologies. Next-generation biomanufacturing methods, including continuous processing, automation, and modular manufacturing systems, enable faster production cycles, higher product quality, and more flexible operations compared with traditional batch manufacturing. This rising demand has strengthened the continuous upstream biomanufacturing segment, which leads the market because it supports large-scale biologics production with improved operational efficiency and a smaller facility footprint. This segment represented approximately 45.3% of the total market share. Government and global health data also emphasize the growing significance of biologics production. According to the World Health Organization (WHO), global biopharmaceutical manufacturing capacity has expanded by over 30% due to investments in flexible and modular production technologies, while the U.S. National Institutes of Health (NIH) reports that continuous bioprocessing can reduce manufacturing cycle times by up to 50%, significantly enhancing efficiency in biologic drug production. These developments indicate that increasing demand for biologics and rising government investment in advanced manufacturing infrastructure are accelerating the global adoption of next-generation biomanufacturing technologies.

Next-Generation Biomanufacturing Market- Segmentation Analysis:

The Global Next-Generation Biomanufacturing Market is segmented on the basis of Product, Application, Workflow Type, End Use, and Region.

The market is divided into three categories based on Product: Continuous Upstream Biomanufacturing Products, Single-Use Upstream Biomanufacturing Products, and Downstream Biomanufacturing Products. The Single-Use Upstream Biomanufacturing Products segment controls the global Next-Generation Biomanufacturing market single-use upstream biomanufacturing products are primarily driven by their ability to reduce contamination risks, lower operational costs, and increase manufacturing flexibility. These products, including disposable bioreactors, single-use bags, and tubing systems, eliminate the need for complex cleaning and sterilization processes required in traditional stainless-steel systems. This advantage significantly shortens production cycles and improves efficiency, which is critical for biopharmaceutical companies producing monoclonal antibodies, vaccines, and cell or gene therapies. According to the U.S. Food and Drug Administration, the number of approved biologics and biosimilar products has increased steadily in recent years, driving demand for faster and more adaptable manufacturing platforms. Additionally, the International Federation of Pharmaceutical Manufacturers & Associations reports that biologics represent a rapidly growing share of global pharmaceutical pipelines, encouraging manufacturers to adopt single-use technologies to accelerate production and scale up quickly. These advantages make single-use upstream systems the most widely adopted product category in next-generation biomanufacturing facilities worldwide.

The market is divided into two categories based on application: Monoclonal Antibodies, Vaccines, Recombinant Proteins, and Hormones. The leadership of monoclonal antibodies (mAbs) is mainly driven by their extensive use in the treatment of cancer, autoimmune disorders, and infectious diseases. Biopharmaceutical companies increasingly prioritize monoclonal antibody development due to their high specificity, strong therapeutic effectiveness, and growing regulatory approvals worldwide. According to the U.S. Food and Drug Administration, monoclonal antibodies account for a significant share of newly approved biologic drugs in recent years, reflecting strong global demand for antibody-based therapies. In addition, the World Health Organization highlights the expanding use of monoclonal antibody treatments in oncology and immune-related diseases, which has increased the need for large-scale and efficient biomanufacturing platforms. Because these therapies require highly controlled and scalable production processes, manufacturers are increasingly adopting advanced upstream and downstream biomanufacturing technologies, thereby strengthening the dominance of the monoclonal antibodies segment in the global market.

Next-Generation Biomanufacturing Market- Geographical Insights

The Next-Generation Biomanufacturing Market shows strong geographical expansion, with North America holding a notable share of the Next-Generation Biomanufacturing market due to the presence of established biotechnology and pharmaceutical companies, advanced research infrastructure, and supportive regulatory systems. The United States contributes significantly to the region through investments in biologics, cell and gene therapy development, and modern manufacturing technologies such as continuous bioprocessing and single-use systems. Government programs and funding from organizations such as the U.S. Department of Health and Human Services and the National Institutes of Health also support the development of advanced biomanufacturing capabilities. At the same time, Europe represents an important region in the market, supported by a well-developed pharmaceutical industry and collaborative research initiatives. Countries including Germany, the United Kingdom, Switzerland, and France are involved in biologics production and biopharmaceutical research, while government programs, academic institutions, and contract development and manufacturing organizations contribute to the steady adoption of next-generation biomanufacturing technologies across the region, strengthening the region's importance in next-generation.

Next-Generation Biomanufacturing Market- Country Insights

In the global Next-Generation Biomanufacturing Market, The United States represents a key country in the Next-Generation Biomanufacturing market due to its well-established biotechnology industry, advanced research infrastructure, and continuous investment in biologics manufacturing technologies. The country hosts numerous biopharmaceutical companies, research institutions, and contract development and manufacturing organizations that support the development and production of biologics, vaccines, and cell and gene therapies. Government initiatives also contribute to market development; for example, the U.S. Department of Health and Human Services has supported programs to strengthen domestic biomanufacturing capabilities and encourage innovation in advanced manufacturing technologies. In addition, collaboration between academic institutions, biotechnology firms, and research organizations supports the gradual adoption of next-generation biomanufacturing methods such as continuous processing, automation, and single-use bioprocessing systems.

Next-Generation Biomanufacturing Market- Competitive Landscape:

The Next-Generation Biomanufacturing Market is intensely competitive and moderately fragmented, with numerous global biotechnology and life sciences companies emphasizing technological innovation, automation, and advanced bioprocessing solutions to enhance their market position. Prominent companies, including Thermo Fisher Scientific, Merck KGaA, Danaher Corporation, Sartorius AG, and GE HealthCare, play a crucial role in the industry by providing sophisticated bioreactors, disposable manufacturing systems, and automated platforms for biologics production. These organizations implement strategies such as collaborations, new product introductions, capacity expansions, and strategic acquisitions to enhance manufacturing productivity and scalability. Additionally, key companies are increasingly investing in continuous biomanufacturing technologies, AI-enabled process monitoring, and flexible modular production facilities to meet the rising demand for biologics, biosimilars, and cell and gene therapies globally, thereby intensifying market competition and driving technological progress across the sector.

Recent Developments:

In March 2023, Sartorius AG and LFB Biomanufacturing collaborated on the creation and production of cell lines. LFB BIOMANUFACTURING is a division of LFB Group, a well-known European business that supplies medical practitioners with plasma-derived pharmaceutical products. It specializes in therapeutic protein biomanufacturing. This collaboration strengthens advanced cell line development capabilities and supports the growing demand for efficient biologics manufacturing across the global biopharmaceutical industry.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Applikon Biotechnology BV (Netherlands),
  • bbi-biotech GmbH (Germany),
  • Danaher Corporation (US),
  • Eppendorf AG (Germany), Esco Group of Companies (US),
  • GEA Group Aktiengesellschaft (Germany),
  • Meissner Filtration Products, Inc. (US),
  • Merck KGaA (Germany),
  • PBS Biotech, Inc. (US),
  • Pierre Guerin (France),
  • Sartorius AG (Germany),
  • Shanghai Bailun Biotechnology Co. Ltd. (China),
  • Solaris Biotechnology Srl. (Italy),
  • Thermo Fisher Scientific Inc. (US),
  • ZETA GmbH (Austria),
  • Others

GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET, BY WORKFLOW TYPE- MARKET ANALYSIS, 2020 - 2033

  • Upstream Biomanufacturing Workflow
  • Downstream Biomanufacturing Workflow

GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • Monoclonal Antibodies
  • Vaccines
  • Recombinant Protein
  • Hormones
  • Others

GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET, BY PRODUCT- MARKET ANALYSIS, 2020 - 2033

  • Continuous Upstream Biomanufacturing Products
  • Single-Use Upstream Biomanufacturing Products
  • Downstream Biomanufacturing Products

GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET, BY End Use- MARKET ANALYSIS, 2020 - 2033

  • Biopharmaceutical Companies
  • Research Institutions
  • Contract Research Organizations

GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Next-Generation Biomanufacturing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Next-Generation Biomanufacturing Market Snippet by Workflow Type
    • 2.1.2. Next-Generation Biomanufacturing Market Snippet by Application
    • 2.1.3. Next-Generation Biomanufacturing Market Snippet by Product
    • 2.1.4. Next-Generation Biomanufacturing Market Snippet by End Use
    • 2.1.5. Next-Generation Biomanufacturing Market Snippet by Country
    • 2.1.6. Next-Generation Biomanufacturing Market Snippet by Region
  • 2.2. Competitive Insights

3. Next-Generation Biomanufacturing Key Market Trends

  • 3.1. Next-Generation Biomanufacturing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Next-Generation Biomanufacturing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Next-Generation Biomanufacturing Market Opportunities
  • 3.4. Next-Generation Biomanufacturing Market Future Trends

4. Next-Generation Biomanufacturing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Next-Generation Biomanufacturing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Next-Generation Biomanufacturing Market Landscape

  • 6.1. Next-Generation Biomanufacturing Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Next-Generation Biomanufacturing Market - By Workflow Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Workflow Type, 2025 & 2033 (%)
    • 7.1.2. Upstream Biomanufacturing Workflow
    • 7.1.3. Downstream Biomanufacturing Workflow

8. Next-Generation Biomanufacturing Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 8.1.2. Monoclonal Antibodies
    • 8.1.3. Vaccines
    • 8.1.4. Recombinant Protein
    • 8.1.5. Hormones
    • 8.1.6. Others

9. Next-Generation Biomanufacturing Market - By Product

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Product, 2025 & 2033 (%)
    • 9.1.2. Continuous Upstream Biomanufacturing Products
    • 9.1.3. Single-Use Upstream Biomanufacturing Products
    • 9.1.4. Downstream Biomanufacturing Products

10. Next-Generation Biomanufacturing Market - By End Use

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 10.1.2. Biopharmaceutical Companies
    • 10.1.3. Research Institutions
    • 10.1.4. Contract Research Organizations

11. Next-Generation Biomanufacturing Market- By Geography

  • 10.2. Introduction
    • 10.2.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 10.3. North America
    • 10.3.1. Overview
    • 10.3.2. Next-Generation Biomanufacturing Key Manufacturers in North America
    • 10.3.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.3.4. North America Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
    • 10.3.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.3.6. North America Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 10.3.7. North America Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.3.8. U.S.
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.8.3. U.S. Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.3.8.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.8.5. U.S. Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.3.8.6. U.S. Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.3.9. Canada
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.9.3. Canada Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.3.9.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.9.5. Canada Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.3.9.6. Canada Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 10.4. Europe
    • 10.4.1. Overview
    • 10.4.2. Next-Generation Biomanufacturing Key Manufacturers in Europe
    • 10.4.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.4.4. Europe Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
    • 10.4.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.4.6. Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 10.4.7. Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.8. Germany
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.8.3. Germany Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.4.8.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.8.5. Germany Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.4.8.6. Germany Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.9. UK
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.9.3. UK Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.4.9.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.9.5. UK Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.4.9.6. UK Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.10. France
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.10.3. France Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.4.10.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.10.5. France Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.4.10.6. France Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.11. Italy
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.11.3. Italy Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.4.11.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.11.5. Italy Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.4.11.6. Italy Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.12. Spain
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.12.3. Spain Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.4.12.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.12.5. Spain Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.4.12.6. Spain Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.13. The Netherlands
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.13.3. The Netherlands Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.4.13.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.13.5. The Netherlands Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.4.13.6. The Netherlands Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.14. Sweden
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.14.3. Sweden Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.4.14.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.14.5. Sweden Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.4.14.6. Sweden Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.15. Russia
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.15.3. Russia Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.4.15.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.15.5. Russia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.4.15.6. Russia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.16. Poland
      • 10.4.16.1. Overview
      • 10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.16.3. Poland Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.4.16.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.16.5. Poland Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.4.16.6. Poland Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.4.17. Rest of Europe
      • 10.4.17.1. Overview
      • 10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.17.3. Rest of the Europe Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.4.17.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.17.5. Rest of the Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.4.17.6. Rest of the Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 10.5. Asia Pacific (APAC)
    • 10.5.1. Overview
    • 10.5.2. Next-Generation Biomanufacturing Key Manufacturers in Asia Pacific
    • 10.5.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.5.4. APAC Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
    • 10.5.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.5.6. APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 10.5.7. APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.5.8. China
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.8.3. China Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.5.8.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.8.5. China Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.5.8.6. China Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.5.9. India
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.9.3. India Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.5.9.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.9.5. India Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.5.9.6. India Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.5.10. Japan
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.10.3. Japan Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.5.10.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.10.5. Japan Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.5.10.6. Japan Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.5.11. South Korea
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.11.3. South Korea Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.5.11.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.11.5. South Korea Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.5.11.6. South Korea Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.5.12. Australia
      • 10.5.12.1. Overview
      • 10.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.12.3. Australia Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.5.12.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.12.5. Australia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.5.12.6. Australia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.5.13. Indonesia
      • 10.5.13.1. Overview
      • 10.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.13.3. Indonesia Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.5.13.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.13.5. Indonesia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.5.13.6. Indonesia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.5.14. Thailand
      • 10.5.14.1. Overview
      • 10.5.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.14.3. Thailand Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.5.14.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.14.5. Thailand Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.5.14.6. Thailand Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.5.15. Philippines
      • 10.5.15.1. Overview
      • 10.5.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.15.3. Philippines Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.5.15.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.15.5. Philippines Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.5.15.6. Philippines Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.5.16. Rest of APAC
      • 10.5.16.1. Overview
      • 10.5.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.16.3. Rest of APAC Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.5.16.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.16.5. Rest of APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.5.16.6. Rest of APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 10.6. Latin America (LATAM)
    • 10.6.1. Overview
    • 10.6.2. Next-Generation Biomanufacturing Key Manufacturers in Latin America
    • 10.6.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.6.4. LATAM Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
    • 10.6.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.6.6. LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 10.6.7. LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.6.8. Brazil
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.8.3. Brazil Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.6.8.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.8.5. Brazil Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.6.8.6. Brazil Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.6.9. Mexico
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.9.3. Mexico Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.6.9.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.9.5. Mexico Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.6.9.6. Mexico Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.6.10. Argentina
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.10.3. Argentina Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.6.10.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.10.5. Argentina Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.6.10.6. Argentina Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.6.11. Colombia
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.11.3. Colombia Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.6.11.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.11.5. Colombia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.6.11.6. Colombia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.6.12. Rest of LATAM
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.12.3. Rest of LATAM Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.6.12.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.12.5. Rest of LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.6.12.6. Rest of LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 10.7. Middle East and Africa (MEA)
    • 10.7.1. Overview
    • 10.7.2. Next-Generation Biomanufacturing Key Manufacturers in Middle East and Africa
    • 10.7.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.7.4. MEA Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
    • 10.7.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.7.6. MEA Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 10.7.7. MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.7.8. Saudi Arabia
      • 10.7.8.1. Overview
      • 10.7.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.7.8.3. Saudi Arabia Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.7.8.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.7.8.5. Saudi Arabia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.7.8.6. Saudi Arabia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.7.9. United Arab Emirates
      • 10.7.9.1. Overview
      • 10.7.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.7.9.3. United Arab Emirates Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.7.9.4. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.7.9.5. United Arab Emirates Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.7.9.6. United Arab Emirates Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.7.10. Israel
      • 10.7.10.1. Overview
      • 10.7.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.7.10.3. Israel Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.7.10.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.7.10.5. Israel Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.7.10.6. Israel Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.7.11. Turkey
      • 10.7.11.1. Overview
      • 10.7.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.7.11.3. Turkey Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.7.11.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.7.11.5. Turkey Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.7.11.6. Turkey Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.7.12. Algeria
      • 10.7.12.1. Overview
      • 10.7.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.7.12.3. Algeria Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.7.12.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.7.12.5. Algeria Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.7.12.6. Algeria Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.7.13. Egypt
      • 10.7.13.1. Overview
      • 10.7.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.7.13.3. Egypt Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.7.13.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.7.13.5. Egypt Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.7.13.6. Egypt Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 10.7.14. Rest of MEA
      • 10.7.14.1. Overview
      • 10.7.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.7.14.3. Rest of MEA Market Size and Forecast, By Workflow Type, 2020 - 2033 (US$ Million)
      • 10.7.14.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.7.14.5. Rest of MEA Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.7.14.6. Rest of MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)

11. Key Vendor Analysis- Next-Generation Biomanufacturing Industry

  • 11.1. Competitive Benchmarking
    • 11.1.1. Competitive Dashboard
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
  • 11.3. Applikon Biotechnology BV (Netherlands),
  • 11.4. bbi-biotech GmbH (Germany),
  • 11.5. Danaher Corporation (US),
  • 11.6. Eppendorf AG (Germany), Esco Group of Companies (US),
  • 11.7. GEA Group Aktiengesellschaft (Germany),
  • 11.8. Meissner Filtration Products, Inc. (US),
  • 11.9. Merck KGaA (Germany),
  • 11.10. PBS Biotech, Inc. (US),
  • 11.11. Pierre Guerin (France),
  • 11.12. Sartorius AG (Germany),
  • 11.13. Shanghai Bailun Biotechnology Co. Ltd. (China),
  • 11.14. Solaris Biotechnology Srl. (Italy),
  • 11.15. Thermo Fisher Scientific Inc. (US),
  • 11.16. ZETA GmbH (Austria),
  • 11.17. Other

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us